Sanofi SA

Type: Company
Name: Sanofi SA
Nationality: France
Web Address: http://en.sanofi.com/
First reported 13 hours ago - Updated 16 mins ago - 2 reports

Sanofi Dumps KaloBios’ P. aeruginosa Antibiotic

Sanofi is handing back full rights to KB001-A, a monoclonal antibody from KaloBios that targets Pseudomonas aeruginosa ( Pa ), a bacterium implicated in pneumonia and lung infections tied to cystic fibrosis.KaloBios isn’t saying what led Sanofi to abandon ... [Published RT Magazine - 16 mins ago]
First reported 22 hours ago - Updated 2 hours ago - 9 reports

Global Healthcare Provider Sanofi Forms Global Marketing Partnership with InnerWorkings

July 28, 2014CHICAGO—July 28, 2014—InnerWorkings Inc., a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies.Under this agreement, InnerWorkings ... [Published Printing Impressions - 19 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Lack of marketing partner delays Afrezza launch

Share this article: No marketing; no money. It's been four weeks since the approval of MannKind's novel inhalable insulin, Afrezza, and the company has yet to find a marketing partner. The drug's failure to launch illustrates the difficulties in post-approval ... [Published Medical Marketing And Media - 8 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Pediapharm Announces Annual Audited Financial Results

) -NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESPediapharm IncHighlights for the period ended March 31, 2014:-- Total revenues for the fifteen-month period ended March 31, 2014 increased by 88% compared to the ... [Published BusinessWeek - 13 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Trading Higher on Heavy Volume are Shares of Sanofi-Aventis on 1.3x Above-Average Volume (SNY)

(Financial News Network On) The price of Sanofi-Aventis shares has climbed to $51.21 (a 0.5% change) on heavy trading volume. Approximately 1.1 million shares have changed hands today vs. average 30-day volume of 861,000 shares. Spikes in volume can ... [Published Individual.com - 16 hours ago]
Entities: Sanofi SA, Stocks
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Sanofi SA Stock Rating Upgraded by Mainfirst (SNY)

Sanofi SA (NYSE:SNY)A number of other analysts have also recently weighed in on SNY. Analysts at Zacks reiterated a "neutral" rating on shares of Sanofi SA in a research note on Friday, June 20th. They now have a $57.00 price target on the stock. Finally, ... [Published American Banking News - 17 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Sanofi Reports Progress Toward First Dengue Vaccine

Sanofi Pasteur, the vaccines division of Sanofi, reports that results of an efficacy study is a step closer to making dengue the next vaccine-preventable disease.Sanofi points to The Lancet’s published results showing the overall efficacy of the drug ... [Published Pharmaceutical Executive - 17 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

How Big Is This Risk for Isis Pharmaceuticals, inc. Stock?

Now for the bad news, Isis has just one second-generation antisense drug on the market, and so far its launch has been disappointing. While the poor initial reception to Kynamro is upsetting, its performance might be the least of the company's worries. ... [Published Motley Fool - 18 hours ago]
First reported Jul 28 2014 - Updated 20 hours ago - 1 reports

Bose Sues Beats, Sanofi Interest, Hershey: Intellectual Property

(This is a daily report on global news about patents, trademarks, copyright and other intellectual property topics. To be sent this column daily, click SALT IPREPORT GO.) July 28 (Bloomberg) -- Bose Corp. filed a patent- infringement action seeking to ... [Published Washington Post - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Sanofi’s $8.5bn mature drug portfolio draws private equity interest

A trio of private equity majors are reportedly interested in French pharmaceutical company Sanofi ’s $8.5bn portfolio of older, off-patent drugs.Sanofi is currently considering options for the mature-drug portfolio, which has drawn interest from KKR, ... [Published AltAssets.net - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Bose Sues Beats, Sanofi, Hershey: Intellectual Property - Bloomberg

Bose Sues Beats, Sanofi, Hershey: Intellectual Property Bloomberg “There has been a climate of controversy that's been entertained in order to maybe endanger the right to be forgotten,” Falque-Pierrotin said in a phone interview with Bloomberg ... [Published Bloomberg via Google News - Jul 28 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

European regulators have for the first time recommended approval of Eli Lilly’s Abasaria, a bio-similar version of Sanofi’s Lantus, which generates approximately $8 billion in yearly sales, as reported in Yahoo!7 News. The European Medicines Agency (EMA), ... [Published FirstWord Pharma - Jul 27 2014]

Quotes

Pritchard added, "We will immediately embark on a process to identify a partner with a focus on infectious disease, hospital pharmaceuticals, or cystic fibrosis who can accelerate and financially support the pivotal studies for KB001-A."
"I think Pfizer felt that the drug would sell itself," Rubin stated. "Samples were sparse, the TV ads were late, and they were too benign and not exciting. They did not court the nurses, the certified diabetic educators, who play an even bigger role than physicians in deciding to put patients on insulin. They ignored them."
"We continue to believe in the potential of this innovative therapy as a means to address Pa infections in a variety of settings" Pritchard said in a statement...
"We are grateful to Sanofi for the work they did to advance the KB001-A program, including their global epidemiology study that supports KaloBios' assumptions about the large market potential for KB001-A in ventilator-associated pneumonia (VAP). At the same time, we are pleased to regain the global rights for KB001-A across all indications" said David Pritchard

More Content

All (1866) | News (1340) | Reports (0) | Blogs (413) | Audio/Video (2) | Fact Sheets (32) | Press Releases (73)
sort by: Date | Relevance
Sanofi Dumps KaloBios’ P. aeruginosa Antibiotic [Published RT Magazine - 16 mins ago]
China's anti-trust regulators [Published Sharenet - 37 mins ago]
MS targeted in Chinese anti-trust probe [Published IT Web - 1 hour ago]
Chronic Kidney Disease Market - Global Analysis... [Published MyNewsDesk - 1 hour ago]
Small Molecule Kinase Inhibitors Market: Pharma... [Published MyNewsDesk - 4 hours ago]
OKBio Scholarship Provides Partnering Experience [Published I2E - 5 hours ago]
KaloBios Regains Global Rights To KB001-A, Ends... [Published Street Sweeper - 6 hours ago]
HOLD/UPDATE 3-Microsoft targeted in apparent Ch... [Published CNBC - 7 hours ago]
KALOBIOS PHARMACEUTICALS : Regains Global Right... [Published 4 Traders - 8 hours ago]
Lack of marketing partner delays Afrezza launch [Published Medical Marketing And Media - 8 hours ago]
KaloBios Regains Global Rights To KB001-A From ... [Published RTTNews.com - 11 hours ago]
Sanofi dumps KaloBios' antibiotic in another st... [Published FierceBiotech - 13 hours ago]
KaloBios Provides Update on KB001-A Partnership... [Published Bio-Medicine - 13 hours ago]
Pediapharm Announces Annual Audited Financial R... [Published BusinessWeek - 13 hours ago]
ESSA Bancorp, Inc. Adding Two Directors to Expa... [Published BusinessWeek - 14 hours ago]
ESSA Bancorp, Inc. Adding Two Directors to Expa... [Published Stockboard Media Inc. - 14 hours ago]
KaloBios Provides Update on KB001-A Partnership... [Published Nasdaq - 14 hours ago]
KaloBios Provides Update on KB001-A Partnership... [Published Industrial Info Financials - 14 hours ago]
Dow recoups 82-point loss as data anticipated [Published Yahoo! Malaysia - 14 hours ago]
Law Experts: Mobile Health Apps Need More FDA R... [Published Laboratory Equipment - 15 hours ago]
The Product Development Story Of Provectus Biop... [Published BioPortfolio - 15 hours ago]
Only 1 in 1000 mHealth Apps Have been Regulated... [Published Healthcare Informatics Online - 16 hours ago]
Stock Analysts’ Upgrades for July, 28th (ARCP, ... [Published American Banking News - 16 hours ago]
More Than Window Dressing: Ornskov Seen As Key ... [Published Health News Daily - 16 hours ago]
Trading Higher on Heavy Volume are Shares of Sa... [Published Individual.com - 16 hours ago]
Gilead: Does It Pass The Trial As A Long-Term I... [Published Seeking Alpha - 16 hours ago]
The Product Development Story Of Provectus Biop... [Published Seeking Alpha - 17 hours ago]
Sanofi SA Stock Rating Upgraded by Mainfirst (SNY) [Published American Banking News - 17 hours ago]
Sanofi Reports Progress Toward First Dengue Vac... [Published Pharmaceutical Executive - 17 hours ago]
Questcor Ate The Steak, Mallinckrodt Likely To ... [Published Seeking Alpha - 17 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Sanofi and InnerWorkings Sign Global Marketing ... [Published EON Retail - 21 hours ago]
CHICAGO--(EON: Enhanced Online News)--InnerWorkings, Inc. (NASDAQ: INWK) a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies. Under this agreement, ...
Sanofi and InnerWorkings Sign Global Marketing ... [Published EON Business - 21 hours ago]
CHICAGO--(EON: Enhanced Online News)--InnerWorkings, Inc. (NASDAQ: INWK) a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies. Under this agreement, ...
Sanofi and InnerWorkings Sign Global Marketing ... [Published EON Communications - 21 hours ago]
CHICAGO--(EON: Enhanced Online News)--InnerWorkings, Inc. (NASDAQ: INWK) a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies. Under this agreement, ...
Sanofi and InnerWorkings Sign Global Marketing ... [Published Business Wire Retail News - 22 hours ago]
CHICAGO--(BUSINESS WIRE)--InnerWorkings, Inc. (NASDAQ: INWK) a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies. Under this agreement, InnerWorkings ...
Sanofi and InnerWorkings Sign Global Marketing ... [Published Business Wire Professional Services News - 22 hours ago]
CHICAGO--(BUSINESS WIRE)--InnerWorkings, Inc. (NASDAQ: INWK) a leading global marketing supply chain company, has been selected as a global marketing partner of Sanofi, one of the world’s most well-known healthcare companies. Under this agreement, InnerWorkings ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Sanofi takes aim at dengue fever [Published Reuters Video: Top News - Jul 11 2014]
Sanofi takes aim at dengue fever [Published Reuters Video: Business - Jul 11 2014]
1

Press Releases

sort by: Date | Relevance
Pharma Stocks under Review -- Impax Laboratorie... [Published Financial Services - Jul 23 2014]
The Zacks Analyst Blog Highlights:Regado Biosci... [Published Financial Services - Jul 10 2014]
Sanofi and Regeneron Announce Positive Results ... [Published GlobeNewswire: Acquisitions News - Jul 09 2014]
Sanofi and Regeneron Announce Positive Results ... [Published Sanofi.com - Last press releases - Jul 09 2014]
FDA Accepts Sanofi’s New Drug Application for B... [Published Sanofi.com - Last press releases - Jul 08 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.